Integer Holdings (ITGR)
(Delayed Data from NYSE)
$126.78 USD
+0.61 (0.48%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $126.86 +0.08 (0.06%) 4:18 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$126.78 USD
+0.61 (0.48%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $126.86 +0.08 (0.06%) 4:18 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Zacks News
Why You Should Add Surmodics (SRDX) Stock to Your Portfolio
by Zacks Equity Research
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
Here's Why You Should Retain PacBio (PACB) Stock for Now
by Zacks Equity Research
PacBio's (PACB) product development activities raise optimism about the stock.
ITGR vs. EW: Which Stock Is the Better Value Option?
by Zacks Equity Research
ITGR vs. EW: Which Stock Is the Better Value Option?
Abbott's (ABT) New Positive Data Favors OCT in Stent Implantation
by Zacks Equity Research
Abbott's (ABT) latest late-breaking data reflects OCT's potential to improve clinical practice related to stent placement.
Masimo's (MASI) Inks Agreement to Improve Patient Outcomes
by Zacks Equity Research
Masimo's (MASI) latest deal with FMOLHS is expected to enhance patient safety and improve patient outcomes.
Phibro (PAHC) Q4 Earnings Miss Estimates, Gross Margin Falls
by Zacks Equity Research
Robust performance across the Animal Health segment is encouraging for Phirbo (PAHC).
Veeva Systems (VEEV) Beats on Q2 Earnings, Revises FY24 Outlook
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal Q2 results reflect impressive performances by both segments.
Catalent (CTLT) Preliminary Q4 Revenues Dampened by Lower Sales
by Zacks Equity Research
Catalent (CTLT) records lower revenues in Biologics segment in its fourth-quarter fiscal 2023, resulting in overall soft preliminary performance.
Medtronic's (MDT) Inceptiv Spinal Cord Stimulator Gets CE Mark
by Zacks Equity Research
Medtronic's (MDT) Inceptiv SCS System is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals.
BrainsWay (BWAY) Expands Foothold in Taiwan With Deep TMS
by Zacks Equity Research
The collaboration between BrainsWay (BWAY) and Unison Healthcare Group signifies a coordinated effort to enhance access and awareness of Deep TMS in Taiwan.
LabCorp (LH) Suffers From Lower COVID Test Sales, Macro Woes
by Zacks Equity Research
Labcorp's (LH) Early Development Research Laboratories business continues to be constrained by NHP-related supply-chain issues.
Charles River (CRL) Collaborates With Fondazione Telethon
by Zacks Equity Research
Charles River (CRL) is excited about Fondazione Telethon's collaboration to produce HQ plasmid DNA for the lentivirus used in ex vivo gene therapy developed by Fondazione Telethon.
Here's Why You Should Retain Hologic (HOLX) Stock for Now
by Zacks Equity Research
Investors are optimistic about Hologic (HOLX) on the expanded global installed base of more than 3,250 Panthers instruments, representing the catalyst for sustained growth.
Veeva Systems (VEEV) to Support Civica Rx Quality Control
by Zacks Equity Research
Veeva Systems' (VEEV) Vault LIMS will streamline internal testing and manufacturing while promoting lead time adherence.
Thermo Fisher (TMO) Launches New Chromosomal Microarray
by Zacks Equity Research
Thermo Fisher's (TMO) CytoScan HD Accel array can save labs weeks or even months by accelerating the time it takes to get findings from cytogenetic research.
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Up (Revised)
by Zacks Equity Research
Strength across businesses and geographies, driven by execution, innovation, and improved underlying fundamentals contributes to Medtronic (MDT) Q1 revenues.
Here's Why Investors Should Retain STERIS (STE) Stock for Now
by Zacks Equity Research
Investors are optimistic about STERIS' (STE) successful integration of the recently-acquired business and raised guidance.
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Down
by Zacks Equity Research
Strength across businesses and geographies, driven by execution, innovation and improved underlying fundamentals, contributes to Medtronic's (MDT) Q1 revenues.
Here's Why You Should Invest in Align Technology (ALGN) Now
by Zacks Equity Research
Investors are optimistic about Align Technology (ALGN), led by Invisalign portfolio expansion and raised guidance.
3 Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
Here's Why You Should Invest in Penumbra (PEN) Stock for Now
by Zacks Equity Research
Investors are upbeat about Penumbra (PEN) on Strong uptake following the launch of Lightning Flash, which accelerated top-line growth.
What's in the Cards for Medtronic (MDT) in Q1 Earnings?
by Zacks Equity Research
Strength across all businesses is likely to drive Medtronic's (MDT) first-quarter performance.
ITGR vs. EW: Which Stock Is the Better Value Option?
by Zacks Equity Research
ITGR vs. EW: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights Abcam, Integer Holdings and RxSight
by Zacks Equity Research
Abcam, Integer Holdings and RxSight are part of the Zacks top Analyst Blog.
TransMedics (TMDX) Acquires Summit Aviation for Organ Transplant
by Zacks Equity Research
TransMedics' (TMDX) acquisition of Summit Aviation is likely to help establish TransMedics Aviation, the first integrated national provider of air logistics dedicated exclusively to organ transplantation.